复发/持续性喉鳞癌全喉切除术后生存预测因素
本研究基于单中心前瞻性数据库,纳入1998至2015年间因放疗或放化疗后复发/持续性喉鳞癌接受全喉切除术的244例患者,分析生存预测因素。结果显示5年总生存率为49%,5年无病生存率为58%。严重合并症(ACE-27量表,HR 3.76;95%CI 1.56-9.06)和复发临床淋巴结阳性(HR 2.91;95%CI 1.74-4.88)是总生存的独立预测因素。
要点
- 严重合并症是总生存的最强预测因素(HR 3.76)。
- 复发临床淋巴结阳性亦独立预测总生存(HR 2.91)。
- 5年总生存率49%,5年无病生存率58%。
核心结论
- 严重合并症状态是总生存的最强预测因素,提示应重视减轻竞争性健康风险。
研究设计与样本
- 单中心前瞻性数据库查询,纳入1998至2015年间因放疗/放化疗后复发/持续性喉鳞癌行全喉切除术的患者244例。
主要发现
- 5年总生存率为49%。
- 5年无病生存率为58%。
- 总生存的独立预测因素包括严重合并症(ACE-27量表;HR 3.76;95%CI 1.56-9.06)和复发临床淋巴结阳性(HR 2.91;95%CI 1.74-4.88)。
临床怎么用
- 可用于风险预测模型,辅助共享决策、术前健康优化及辅助治疗的患者选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total laryngectomy remains the treatment of choice for recurrent/persistent laryngeal squamous cell carcinoma (SCC) after radiotherapy (RT) or chemoradiotherapy (CRT). However, despite attempts at aggressive surgical salvage, survival in this cohort remains suboptimal. METHODS: A prospectively maintained single-institution database was queried for patients undergoing total laryngectomy for recurrent/persistent laryngeal SCC after initial RT/CRT between 1998 and 2015(n = 244). Demographic, clinical, and survival data were abstracted. The Kaplan-Meier survival curves and hazard ratios (HRs) were calculated. RESULTS: Five-year overall survival (OS) was 49%. Five-year disease-free survival (DFS) was 58%. Independent predictors of OS included severe comorbidity (Adult Comorbidity Evaluation-27 [ACE-27] scale; HR 3.76; 95% confidence interval [CI] 1.56-9.06), and positive recurrent clinical nodes (HR 2.91; 95% CI 1.74-4.88). CONCLUSION: Severe comorbidity status is the strongest predictor of OS, suggesting that increased attention to mitigating competing risks to health is critical. These data may inform a risk prediction model to allow for focused shared decision making, preoperative health optimization, and patient selection for adjuvant therapies.
引用
- Birkeland AC, Beesley L, Bellile E, et al. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck. 2017. PMID: 28963806. doi:10.1002/hed.24918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。